Novartis withdraws bid to block US Regeneron imports

04-05-2021

Muireann Bolger

Novartis withdraws bid to block US Regeneron imports

Taljat David / Shutterstock.com

Pharmaceutical company Novartis has abandoned its attempt to halt US imports of Regeneron’s Eylea pre-filled syringes amid concerns that such a ban could hinder public access to essential treatments.


Novartis, Regeneron, Eylea, imports, patents, infringement

LSIPR